Oncolytic virus

Results: 117



#Item
51ICH Considerations on Viral/Vector Shedding

ICH Considerations on Viral/Vector Shedding

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2014-01-06 12:24:25
52RECOMBINANT DNA ADVISORY COMMITTEE Minutes of Meeting September 9-10, 2008 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service

RECOMBINANT DNA ADVISORY COMMITTEE Minutes of Meeting September 9-10, 2008 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2013-12-09 15:24:27
53Novel Crocetin Compound for Prevention and Therapy of Pancreatic Cancer Summary: This invention is a novel anti-oncolytic therapy, in combination with gemcitabine or 5-FU, to fight pancreatic cancer with high efficacy an

Novel Crocetin Compound for Prevention and Therapy of Pancreatic Cancer Summary: This invention is a novel anti-oncolytic therapy, in combination with gemcitabine or 5-FU, to fight pancreatic cancer with high efficacy an

Add to Reading List

Source URL: kuic.ku.edu

Language: English - Date: 2014-01-30 10:28:38
54

PDF Document

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2013-12-10 12:11:26
55GTSAB REPORT Recombinant DNA Advisory Committee

GTSAB REPORT Recombinant DNA Advisory Committee

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2013-12-31 13:21:48
56Going viral When it comes to cancer prevention, the tumor suppressor p53 is something of a jack-of-all-trades. It can activate repair proteins when a cell’s DNA has sustained damage. It

Going viral When it comes to cancer prevention, the tumor suppressor p53 is something of a jack-of-all-trades. It can activate repair proteins when a cell’s DNA has sustained damage. It

Add to Reading List

Source URL: www.salk.edu

Language: English - Date: 2012-04-12 21:10:34
57Tocagen Presentation to the RAC June 17, 2009 Manish Aghi, M.D., Ph.D. Asst. Professor, Dept. of Neurosurgery University of California, San Francisco

Tocagen Presentation to the RAC June 17, 2009 Manish Aghi, M.D., Ph.D. Asst. Professor, Dept. of Neurosurgery University of California, San Francisco

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2014-01-06 12:40:23
58in this issue © The American Society of Gene & Cell Therapy doi:[removed]mt[removed]

in this issue © The American Society of Gene & Cell Therapy doi:[removed]mt[removed]

Add to Reading List

Source URL: www.nature.com

Language: English - Date: 2014-08-01 03:45:25
59This Week in Virology with Vincent Racaniello, Ph.D. Episode 131: A REOstat for cancer Hosts: Vincent Racaniello, Dickson Despommier, Alan Dove Guest: Brad Thompson, CEO of Oncolytics Biotech

This Week in Virology with Vincent Racaniello, Ph.D. Episode 131: A REOstat for cancer Hosts: Vincent Racaniello, Dickson Despommier, Alan Dove Guest: Brad Thompson, CEO of Oncolytics Biotech

Add to Reading List

Source URL: www.twiv.tv

Language: English - Date: 2012-11-29 12:48:47
60Published OnlineFirst November 24, 2010; DOI:[removed].CCR[removed]A Phase I Study of the Combination of Intravenous Reovirus Type 3 Dearing and Gemcitabine in Patients with Advanced Cancer Martijn P. Lolkema, H

Published OnlineFirst November 24, 2010; DOI:[removed].CCR[removed]A Phase I Study of the Combination of Intravenous Reovirus Type 3 Dearing and Gemcitabine in Patients with Advanced Cancer Martijn P. Lolkema, H

Add to Reading List

Source URL: www.oncolyticsbiotech.com

Language: English - Date: 2013-12-24 04:35:54